A prostate cancer drug won’t be offered on the NHS any earlier in the treatment plans of patients living with the disease in England.
Our scientists have uncovered a new marker that's found on treatment-resistant prostate cancer cells.
Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage.
A type of specialist MRI scan has been recommended as one of the first tests for diagnosing people with suspected prostate cancer
Trial finds prostate radiotherapy plus standard treatment improves survival for some men whose prostate cancer has spread, which could help thousands in the UK.
Treating the prostate with radiotherapy alongside standard treatment led to a 11 per cent* increase in survival for some men with advanced prostate cancer.
The prostate cancer drug abiraterone has been provisionally rejected as a first-line treatment on the NHS in England.
By studying small differences in our DNA, called SNPs, our scientists are showing how these could be used to help prevent cancer in the future.
Questions are being asked of the tests used to diagnose prostate cancer, and how they can be improved. We cover the latest research, including specialist MRI.